Patents-Review.com
🔗 Permalink
Assignee profile:

FERRING B.V.

City:

Hoofddorp

Country:

Netherlands

Published Applications:

229

Last publication date:

2026-05-21

Patent Grants:

171

Last grant date:

2025-11-25

Quarterly FERRING B.V. Patent Applications

Top Inventors for applications by FERRING B.V.

These are the the leading inventors for applications assigned to FERRING B.V.:

Recent patent applications by FERRING B.V.

FERRING B.V. based in Hoofddorp, NL has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2026-05-21
US20260137790A1
Human necessities

MIXED VASOPRESSIN RECEPTOR AGONIST-ANTAGONIST FOR MODULATING MEAN ARTERIAL PRESSURE

 #2 | 2026-05-07
US20260124269A1
Human necessities

METHODS OF TREATING PROSTATE CANCER WITH GnRH ANTAGONIST

 #3 | 2026-01-15
US20260014128A1
Human necessities

STABILIZED LIQUID FORMULATIONS CONTAINING PICOSULFATE

 #4 | 2026-01-15
US20260014104A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING CYSTITIS

 #5 | 2025-12-04
US20250367262A1
Human necessities

COMPOSITIONS AND METHODS FOR INTRAUTERINE INSEMINATION (IUI)

 #6 | 2025-11-20
US20250352621A1
Human necessities

STABLE LIQUID GONADOTROPIN FORMULATION

 #7 | 2025-10-30
US20250333466A1
Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR TREATMENT OF INFERTILITY IN MALES

 #8 | 2025-10-23
US20250325637A1
Human necessities

COMPOSITIONS AND METHODS FOR CONTROLLED OVARIAN STIMULATION

 #9 | 2025-10-02
US20250302923A1
Human necessities

HUMAN-DERIVED RECOMBINANT FSH FOR CONTROLLED OVARIAN STIMULATION

 #10 | 2025-10-02
US20250302888A1
Human necessities

MICROBIOTA RESTORATION THERAPY (MRT) COMPOSITIONS AND METHODS OF MANUFACTURE

 #11 | 2025-09-25
US20250296967A1
Chemistry; metallurgy

COMPOSITION AND METHOD FOR DELIVERY OF BMP-2 AMPLIFIER/CO-ACTIVATOR FOR ENHANCEMENT OF OSTEOGENESIS

 #12 | 2025-09-11
US20250281553A1
Human necessities

BACTERIOPHAGE THERAPY AGAINST ADHERENT-INVASIVE ESCHERICHIA COLI

 #13 | 2025-07-31
US20250241993A1
Human necessities

MIXED PROTOCOL FOR TREATMENT OF INFERTILITY

 #14 | 2025-05-01
US20250134948A1
Human necessities

METHOD OF TREATING PROSTATE CANCER WITH GnRH ANTAGONIST

 #15 | 2025-04-24
US20250127843A1
Human necessities

ADRENOCORTICOTROPIC HORMONE PEPTIDE COMPOSITIONS AND METHODS OF USE

 #16 | 2025-04-10
US20250114434A1
Human necessities

COMPOSITION FOR CONTROLLED OVARIAN STIMULATION

 #17 | 2025-02-20
US20250057921A1
Human necessities

METHODS OF TREATING INFERTILITY

 #18 | 2025-01-30
US20250034206A1
Chemistry; metallurgy

METHOD OF PROTEIN PURIFICATION

 #19 | 2024-12-05
US20240398704A1
Human necessities

ORAL LIQUID ENZALUTAMIDE COMPOSITIONS

 #20 | 2024-10-31
US20240361338A1
Physics

DIAGNOSIS AND TREATMENT OF ECTOPIC ENDOMETRIOSIS

 #21 | 2024-10-17 ✅ Patent 12,478,652 granted on 2025-11-25
US20240342230A1
Human necessities

BACTERIOPHAGE THERAPY

 #22 | 2024-09-26 ✅ Patent 12,514,898 granted on 2026-01-06
US20240316142A1
Human necessities

METHODS OF TREATING PROSTATE CANCER WITH GnRH ANTAGONIST

 #23 | 2024-08-29
US20240287468A1
Chemistry; metallurgy

BACTERIOPHAGES AGAINST VANCOMYCIN-RESISTANT ENTEROCOCCI

 #24 | 2024-03-14
US20240082344A1
Human necessities

METHOD OF TREATING PRADER-WILLI SYNDROME

 #25 | 2024-02-01
US20240033329A1
Human necessities

COMPOSITIONS AND METHODS FOR CONTROLLED OVARIAN STIMULATION

 #26 | 2024-01-25
US20240024424A1
Human necessities

COMPOSITION FOR CONTROLLED OVARIAN STIMULATION

 #27 | 2024-01-18
US20240016753A1
Human necessities

PHARMACEUTICAL COMPOSITIONS

 #28 | 2024-01-11
US20240009278A1
Human necessities

METHODS OF TREATING INFERTILITY

 #29 | 2023-11-23 ✅ Patent 12,447,196 granted on 2025-10-21
US20230372447A1
Human necessities

STABLE LIQUID GONADOTROPIN FORMULATION

 #30 | 2023-11-09 ✅ Patent 12,139,558 granted on 2024-11-12
US20230357322A1
Chemistry; metallurgy

Method of manufacturing a pharmaceutical composition

 #31 | 2023-11-02 ✅ Patent 12,016,955 granted on 2024-06-25
US20230346704A1
Human necessities

Pharmaceutical formulations

 #32 | 2023-08-10
US20230248807A1
Human necessities

HP-HMG FOR USE IN THE TREATMENT OF INFERTILITY IN A PATIENT WITH POLYCYSTIC OVARY SYNDROME

 #33 | 2023-07-06
US20230210955A1
Human necessities

COMPOSITION COMPRISING HP-HMG FOR USE IN TREATING INFERTILITY

 #34 | 2023-06-29
US20230201281A1
Human necessities

VAGINAL MICROBIOTA COMPOSITIONS

 #35 | 2023-05-25
US20230158044A1
Human necessities

MONOLITHIC INTRAVAGINAL RINGS COMPRISING PROGESTERONE AND METHODS OF MAKING AND USES THEREOF

 #36 | 2023-05-25
US20230157979A1
Human necessities

TOPICAL DICLOFENAC COMPOSITIONS AND METHODS

 #37 | 2023-05-04
US20230139407A1
Human necessities

RECOMBINANT FSH COMPOSITION FOR TREATMENT OF INFERTILITY

 #38 | 2023-04-20
US20230124105A1
Human necessities

PHARMACEUTICAL COMPOSITION

 #39 | 2022-11-24 ✅ Patent 12,478,660 granted on 2025-11-25
US20220370567A1
Human necessities

HUMAN-DERIVED RECOMBINANT FSH FOR CONTROLLED OVARIAN

 #40 | 2022-11-24 ✅ Patent 12,458,634 granted on 2025-11-04
US20220370427A1
Human necessities

STABILIZED LIQUID FORMATIONS CONTAINING PICOSULFATE

 #41 | 2022-10-27 ✅ Patent 12,234,272 granted on 2025-02-25
US20220340634A1
Chemistry; metallurgy

Pharmaceutical preparation comprising recombinant HCG

 #42 | 2022-10-06
US20220313774A1
Human necessities

INTRANASAL ADMINISTRATION OF MEROTOCIN FOR IMPROVING LACTATION

 #43 | 2022-07-21 ✅ Patent 11,826,397 granted on 2023-11-28
US20220226422A1
Human necessities

Method of treating prostate cancer with GnRH antagonist

 #44 | 2022-07-14
US20220218782A1
Human necessities

METHODS OF TREATING PROSTATE CANCER WITH GnRH ANTAGONIST

 #45 | 2022-05-19 ✅ Patent 11,931,466 granted on 2024-03-19
US20220151946A1
Human necessities

Process for the preparation of drug loaded microparticles

 #46 | 2022-05-19 ✅ Patent 11,865,207 granted on 2024-01-09
US20220151918A1
Human necessities

Topical pharmaceutical composition for treatment of anal fissures and hemorrhoids

 #47 | 2022-04-21 ✅ Patent 11,963,995 granted on 2024-04-23
US20220118046A1
Human necessities

Methods comprising desmopressin

 #48 | 2022-02-24
US20220054582A1
Human necessities

METHOD FOR MANUFACTURING A SOLID FORMULATION FOR ORAL ADMINISTRATION, ASSOCIATED FACILITY AND SOLID FORUMULATION

 #49 | 2022-02-10
US20220040094A1
Human necessities

DRUG-DEVICE UNIT CONTAINING QUINAGOLIDE

 #50 | 2022-02-03 ✅ Patent 12,533,387 granted on 2026-01-27
US20220031801A1
Human necessities

METHODS OF TREATING PROSTATE CANCER WITH GnRH ANTAGONIST

 #51 | 2022-01-13
US20220008499A1
Human necessities

COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING SEPSIS

 #52 | 2021-12-16 ✅ Patent 11,918,613 granted on 2024-03-05
US20210386805A1
Human necessities

Bacteriophage therapy

 #53 | 2021-12-09 ✅ Patent 12,539,306 granted on 2026-02-03
US20210379081A1
Human necessities

MUCOADHESIVE PHARMACEUTICAL COMPOSITIONS OF CORTICOSTEROIDS

 #54 | 2021-11-18 ✅ Patent 12,311,012 granted on 2025-05-27
US20210353717A1
Human necessities

Compositions and methods for controlled ovarian stimulation

 #55 | 2021-11-11 ✅ Patent 12,173,040 granted on 2024-12-24
US20210347838A1
Chemistry; metallurgy

Composition and method for delivery of BMP-2 amplifier/co-activator for enhancement of osteogenesis

 #56 | 2021-10-07 ✅ Patent 11,673,918 granted on 2023-06-13
US20210309699A1
Chemistry; metallurgy

Method of manufacturing a pharmaceutical composition

 #57 | 2021-10-07 ✅ Patent 12,303,850 granted on 2025-05-20
US20210308642A1
Performing operations; transporting

Miniaturised device for automated manufacture of pharmaceutical compositions, and associated method

 #58 | 2021-09-16
US20210283197A1
Human necessities

MICROBIOTA RESTORATION THERAPY (MRT) COMPOSITIONS AND METHODS OF MANUFACTURE

 #59 | 2021-08-05 ✅ Patent 11,666,635 granted on 2023-06-06
US20210236600A1
Human necessities

Stable liquid gonadotropin formulation

 #60 | 2021-08-05 ✅ Patent 11,648,201 granted on 2023-05-16
US20210236426A1
Human necessities

Pharmaceutical formulations

 #61 | 2021-07-22
US20210220281A1
Human necessities

ORAL PHARMACEUTICAL COMPOSITIONS OF MESALAZINE

 #62 | 2021-07-01 ✅ Patent 11,712,422 granted on 2023-08-01
US20210196647A1
Human necessities

Pharmaceutical compositions comprising activated carbon

 #63 | 2021-06-03 ✅ Patent 11,931,398 granted on 2024-03-19
US20210161995A1
Human necessities

Terlipressin compositions and uses thereof

 #64 | 2021-05-13 ✅ Patent 11,510,962 granted on 2022-11-29
US20210138024A1
Human necessities

Manufacture of degarelix

 #65 | 2021-05-06 ✅ Patent 11,766,468 granted on 2023-09-26
US20210128673A1
Human necessities

Method of treating prostate cancer with GnRH antagonist

 #66 | 2021-04-01 ✅ Patent 11,679,145 granted on 2023-06-20
US20210093697A1
Human necessities

Methods of treating infertility

 #67 | 2021-03-18 ✅ Patent 11,260,102 granted on 2022-03-01
US20210077564A1
Human necessities

Manufacture of Degarelix

 #68 | 2021-03-18
US20210077415A1
Human necessities

ORAL LIQUID PHARMACEUTICAL COMPOSITIONS OF AMINOSALICYLATES

 #69 | 2021-02-11
US20210038694A1
Human necessities

COMPOSITION FOR CONTROLLED OVARIAN STIMULATION

 #70 | 2020-12-31 ✅ Patent 11,413,294 granted on 2022-08-16
US20200405732A1
Human necessities

Monolithic intravaginal rings comprising progesterone and methods of making and uses thereof

 #71 | 2020-11-12 ✅ Patent 11,439,686 granted on 2022-09-13
US20200353053A1
Human necessities

Recombinant FSH composition for treatment of infertility

 #72 | 2020-11-12 ✅ Patent 11,752,157 granted on 2023-09-12
US20200352962A1
Human necessities

Oxytocin receptor antagonist therapy in the luteal phase for implantation and pregnancy in women undergoing assisted reproductive technologies

 #73 | 2020-11-05 ✅ Patent 11,291,708 granted on 2022-04-05
US20200345814A1
Human necessities

Human-derived recombinant FSH for controlled ovarian stimulation

 #74 | 2020-08-27 ✅ Patent 11,202,813 granted on 2021-12-21
US20200268815A1
Human necessities

bacterium for treatment of e.g. bacterial vaginosis

 #75 | 2020-08-06 ✅ Patent 11,292,824 granted on 2022-04-05
US20200247863A1
Chemistry; metallurgy

Pharmaceutical preparation comprising recombinant hCG

 #76 | 2020-07-30 ✅ Patent 10,973,870 granted on 2021-04-13
US20200237854A1
Human necessities

Methods of treating prostate cancer with GnRH antagonist

 #77 | 2020-07-09 ✅ Patent 10,981,955 granted on 2021-04-20
US20200216500A1
Chemistry; metallurgy

Method of manufacturing a pharmaceutical composition

 #78 | 2020-07-09
US20200216493A1
Chemistry; metallurgy

ANTIMICROBIAL PEPTIDES

 #79 | 2020-06-25 ✅ Patent 11,744,879 granted on 2023-09-05
US20200197493A1
Human necessities

Recombinant FSH composition for controlled ovarian stimulation

 #80 | 2020-04-30
US20200129584A1
Human necessities

METHOD OF TREATING PRADER-WILLI SYNDROME

 #81 | 2020-04-23 ✅ Patent 11,306,136 granted on 2022-04-19
US20200123226A1
Chemistry; metallurgy

Selective IL-6-trans-signalling inhibitor compositions

 #82 | 2020-04-02
US20200102348A1
Chemistry; metallurgy

ANGIOTENSIN-1-RECEPTOR ANTAGONISTS

 #83 | 2020-03-26 ✅ Patent 11,351,228 granted on 2022-06-07
US20200093893A1
Human necessities

Methods of treating infertility

 #84 | 2019-11-28 ✅ Patent 10,952,959 granted on 2021-03-23
US20190358156A1
Human necessities

Fast disintegrating pharmaceutical composition

 #85 | 2019-11-21
US20190351060A1
Human necessities

Rectal Foam Formulations

 #86 | 2019-10-24 ✅ Patent 11,078,244 granted on 2021-08-03
US20190322712A1
Chemistry; metallurgy

Composition and method for delivery of BMP-2 amplifler/co-activator for enhancement of osteogenesis

 #87 | 2019-07-25 ✅ Patent 10,765,721 granted on 2020-09-08
US20190224271A1
Human necessities

Manufacture of Degarelix

 #88 | 2019-06-27 ✅ Patent 10,745,443 granted on 2020-08-18
US20190194257A1
Chemistry; metallurgy

Vasopressin-2 receptor agonists

 #89 | 2019-05-09 ✅ Patent 11,020,448 granted on 2021-06-01
US20190134146A1
Human necessities

Methods comprising desmopressin

 #90 | 2019-05-09
US20190134081A1
Human necessities

COMPOSITION FOR THE TREATMENT OF DISEASE

 #91 | 2019-04-11 ✅ Patent 10,874,617 granted on 2020-12-29
US20190105275A1
Human necessities

Oral pharmaceutical compositions of mesalazine

 #92 | 2019-02-28 ✅ Patent 10,792,334 granted on 2020-10-06
US20190060409A1
Human necessities

Stable liquid gonadotropin formulation

 #93 | 2019-01-03 ✅ Patent 10,906,953 granted on 2021-02-02
US20190002518A1
Chemistry; metallurgy

Methods of purification and/or viral inactivation

 #94 | 2018-12-27 ✅ Patent 10,512,695 granted on 2019-12-24
US20180369392A1
Human necessities

Fast dissolving pharmaceutical composition

 #95 | 2018-10-04 ✅ Patent 10,519,218 granted on 2019-12-31
US20180282396A1
Chemistry; metallurgy

Selective IL-6-trans-signalling inhibitor compositions

 #96 | 2018-10-04 ✅ Patent 10,307,459 granted on 2019-06-04
US20180280469A1
Human necessities

Pharmaceutical formulations of desmopressin

 #97 | 2018-09-20 ✅ Patent 10,117,829 granted on 2018-11-06
US20180263897A1
Human necessities

Diclofenac formulations

 #98 | 2018-08-16 ✅ Patent 10,588,926 granted on 2020-03-17
US20180228850A1
Human necessities

bacterium for treatment of e.g. bacterial vaginosis

 #99 | 2018-07-26 ✅ Patent 10,617,644 granted on 2020-04-14
US20180207098A1
Human necessities

Composition for the treatment of fistula

 #100 | 2018-05-10 ✅ Patent 10,464,984 granted on 2019-11-05
US20180127477A1
Chemistry; metallurgy

Optimized nucleic acid sequences coding for the alpha-chain of human chorionic gonadotropin

Also check out Ferring B.V.'s (Hoofddorp, Netherlands) applicant profile with 119 patent applications submitted.

AssigneeID:

6082 ⎘